Skip to main content
OXFORD NANOPORE TECHNOLOGIES PLC logo

OXFORD NANOPORE TECHNOLOGIES PLC — Investor Relations & Filings

Ticker · ONT ISIN · GB00BP6S8Z30 LEI · 213800IRWQ2Q6M2CDW55 IL Manufacturing
Open in API
Filings indexed 371 across all filing types
Latest filing 2023-04-13 Director's Dealing
Country GB United Kingdom
Listing IL ONT

About OXFORD NANOPORE TECHNOLOGIES PLC

https://nanoporetech.com/

Oxford Nanopore Technologies PLC develops and commercializes a proprietary technology platform for DNA and RNA sequencing. The company's core technology is based on nanopore sensing, which enables the direct, real-time analysis of single molecules. This electronic method facilitates the sequencing of native nucleic acids, generating long-read data without requiring amplification. The platform is uniquely scalable, offering a range of products from portable, pocket-sized devices like the MinION to high-throughput instruments for population-scale projects. This technology provides researchers with immediate access to data, enabling rapid insights across various fields of biological research, including human genetics, cancer research, microbiology, and environmental science.

Recent filings

Filing Released Lang Actions
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is titled 'Director/PDMR Notification' and details the purchase of ordinary shares by Duncan Tatton-Brown, identified as the Chair and a Person Discharging Managerial Responsibilities (PDMR). It explicitly references compliance with Article 19 of the UK Market Abuse Regulation. This content directly relates to reporting personal share transactions by company directors and executives (insider trades). This matches the definition for Director's Dealing (DIRS). The presence of the RNS Number and the closing statement about RNS confirms it is a regulatory announcement, but the specific content points strongly to DIRS over the general RNS fallback.
2023-04-13 English
Share Incentive Plan - Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is a formal notification of share transactions by Persons Discharging Managerial Responsibilities (PDMRs), specifically Tim Cowper and Clive Brown of Oxford Nanopore Technologies plc. It details the purchase of partnership shares and the grant of matching shares under a Share Incentive Plan (SIP). This type of disclosure is a standard regulatory requirement for insider trading/director dealings under the UK Market Abuse Regulation, which maps directly to the 'Director's Dealing' (DIRS) category.
2023-04-12 English
LTIP and DBP; Director/PDMR Notification
Director's Dealing Classification · 98% confidence The document is an RNS (Regulatory News Service) announcement dated April 12, 2023, detailing transactions by Persons Discharging Managerial Responsibilities (PDMRs), specifically the grant of LTIP and DBP awards, and the vesting/sale of shares by directors (Clive Brown, Timothy Cowper, Gordon Sanghera, Spike Willcocks). The filing explicitly states it is made pursuant to Article 19 of the UK Market Abuse Regulation and uses the RNS numbering system. This content directly relates to insider trading/executive share dealings, which maps precisely to the 'Director's Dealing' definition. Although it is distributed via RNS, the specific content dictates the classification should be DIRS (Director's Dealing) over the general RNS fallback, as DIRS is a more specific category for this type of disclosure.
2023-04-12 English
NIH Alzheimers study shows scaled, accurate data
Regulatory Filings Classification · 100% confidence The document begins with an 'RNS Number' and is dated April 11, 2023. It announces a publication from a research team (NIH CARD) detailing the successful application of Oxford Nanopore's technology (PromethION) for high-accuracy genome sequencing. The content is a press release detailing a scientific/technological achievement and its implications, rather than a mandatory financial filing like a 10-K, an earnings release (ER), or a formal capital structure update (CAP). The footer explicitly states, 'This information is provided by Reach, the non-regulatory press release distribution service of RNS...' and 'Reach is a non-regulatory news service.' This strongly suggests it is a general announcement or press release that does not fit the specific financial/regulatory codes (10-K, ER, DIV, etc.). Given the options, 'Regulatory Filings' (RNS) is the most appropriate fallback for a non-regulatory press release distributed via the RNS system that doesn't match other specific categories like Management Changes (MANG) or Capital Updates (CAP). However, since it is a general announcement about company technology/research success, and the document itself is a press release, RNS (as the general regulatory/announcement channel) is the best fit among the provided codes for non-core financial disclosures.
2023-04-11 English
Block listing Interim Review
Regulatory Filings Classification · 95% confidence The document is identified by the header 'RNS Number : 6788V' and contains information related to a 'BLOCK LISTING SIX MONTHLY RETURN' for Oxford Nanopore Technologies plc, covering a period from October 2022 to April 2023. This type of periodic return detailing the balance of unallotted securities under share option schemes is a specific regulatory filing requirement, often submitted via the RNS system. Since there is no specific code for a 'Block Listing Return' and it is a mandatory regulatory disclosure provided through the RNS service, it best fits the general 'Regulatory Filings' category (RNS) or potentially 'Share Issue/Capital Change' (SHA). However, given the context of RNS distribution and the nature of the filing (a routine return to maintain listing compliance rather than a primary corporate action announcement like a new issue), RNS is the most appropriate general classification for miscellaneous regulatory updates distributed via this channel. The document is short and is a direct filing, not an announcement of a filing.
2023-04-06 English
Issue of Equity and Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a formal announcement disseminated via RNS (Regulatory News Service) of the London Stock Exchange. It explicitly details the 'Issue of Equity and Total Voting Rights' as of March 31, 2023, following option exercises and remuneration schemes. This involves a change in the total number of shares and voting rights, which is a specific corporate action. While it relates to share capital changes (SHA), the primary function here is the mandatory notification of the resulting total voting rights count to the market, as required by the FCA's Disclosure Guidance and Transparency Rule 5.6.1. Since the document is a short, mandatory regulatory update concerning share structure and voting rights, and it is distributed via RNS, it fits best under the general 'Regulatory Filings' (RNS) category, as it is not a comprehensive report (like 10-K or IR) nor solely a declaration of past voting results (DVA). However, given the specific content about share issuance and total voting rights, 'Share Issue/Capital Change' (SHA) is also highly relevant. Since the core purpose is the mandatory disclosure of the total voting rights denominator, which is a standard regulatory filing requirement, RNS is a strong fit, but SHA captures the substance better than the general fallback. Let's re-evaluate the definitions: SHA is for 'Announcement regarding new share issues, stock splits, or other capital changes.' This document announces a new share issue and the resulting total voting rights. Therefore, SHA is the most precise fit.
2023-04-03 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.